Ardsley Advisory Partners LP Legend Biotech Corp Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $3.03 Million - $3.85 Million	55,000 Added 64.71%	140,000 $7.85 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $4.74 Million - $5.74 Million	-75,000 Reduced 46.88%	85,000 $5.71 Million
Q2 2023 Aug 14, 2023	SELL	$46.28 - $75.01 $925,600 - $1.5 Million	-20,000 Reduced 11.11%	160,000 $11 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $7.82 Million - $10.3 Million	180,000 New	180,000 $8.68 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $2.72 Million - $4.46 Million	81,000 New	81,000 $4.46 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.